RxDoctor Payments Data

Ashraf Mikhail, MD

Psychiatry · Jacksonville, NCNPI 1083690515

Payments from drug & device makers

$3,749in general payments, 2019–2025

Across 271 payments — averaging $13.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$432
  • Otsuka America Pharmaceutical, Inc.$425
  • Supernus Pharmaceuticals, Inc.$346
  • Johnson & Johnson$291
  • Teva Pharmaceuticals USA, Inc.$244
  • plus $893 from 15 others

What the payments were for

  • Food & beverage$3,749100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,749 in reported general payments places this provider in the 85th percentile of 1,108 psychiatry providers in North Carolina.

See all psychiatry providers in North Carolina

Medicare billing

Part B allowed, 2024
$75,697
Medicare patients
138
Services billed
614

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine14$150,839
NuplazidPimavanserin Tartrate21$131,779
VraylarCariprazine Hcl38$68,358
SuboxoneBuprenorphine Hcl/Naloxone Hcl87$67,309
AuvelityDextromethorphan Hbr/Bupropion44$39,324
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl124$23,623
RexultiBrexpiprazole11$18,217
Paliperidone ErPaliperidone41$9,096
FetzimaLevomilnacipran Hcl12$6,693
ZubsolvBuprenorphine Hcl/Naloxone Hcl12$5,678
Duloxetine Hcl168$4,260
Doxepin Hcl102$3,768
Lisdexamfetamine Dimesylate23$3,171
Atomoxetine Hcl25$2,968
Lurasidone Hcl51$2,802

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$244$150,83914 claims
AbbVieVraylar, Fetzima$1,118$75,05150 claims
Axsome Therapeutics, Inc.Auvelity$145$39,32444 claims
Otsuka America Pharmaceutical, Inc.Rexulti$425$18,21711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,108 psychiatry providers in North Carolina.

Other psychiatry in Jacksonville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →